Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

This early-stage study tested a new injection called HDM1005 in 40 overweight or obese adults. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effects and drug levels …

This early-stage study tested a single dose of HDM1005 in 65 healthy adults to check its safety and how the body processes it. Researchers also looked at changes in weight and other health markers. The goal is to see if this drug could help with weight management in the future.

This study tested a cream called roflumilast (ZORYVE®) on 354 people aged 6 and older with mild to moderate atopic dermatitis (eczema). Participants applied the cream or a placebo once daily for 4 weeks. The goal was to see if the cream could clear or nearly clear the skin rash. …